down arrow

Akums Drugs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
439.00
9.25 (2.15%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Supriya Lifesci.
Divi's Lab.
Aarti Pharma
Cipla
Strides Pharma
Sun Pharma.Inds.
Torrent Pharma
Shilpa Medicare
Mankind Pharma
FDC
Akums Drugs
Why is Akums Drugs & Pharmaceuticals Ltd ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
14.30%
EBIT Growth (5y)
-101.18%
EBIT to Interest (avg)
2.41
Debt to EBITDA (avg)
4.31
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
1.24
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.36%
ROCE (avg)
-0.10%
ROE (avg)
11.75%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
308
Industry P/E
33
Price to Book Value
2.39
EV to EBIT
-2443.42
EV to EBITDA
52.85
EV to Capital Employed
2.53
EV to Sales
1.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.10%
ROE (Latest)
0.78%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Bearish
KST
Dow Theory
Bearish
Bearish
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 23.66 times

PBT LESS OI(Q)

At Rs 71.71 cr has Grown at 77.7% (vs previous 4Q average

PAT(9M)

Higher at Rs 184.39 Cr

-3What is not working for the Company
PAT(Latest six months)

At Rs 124.22 cr has Grown at -47.11%

Loading Valuation Snapshot...
Here's what is working for Akums Drugs
Operating Profit to Interest - Quarterly
Highest at 23.66 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 71.71 cr has Grown at 77.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 40.36 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Here's what is not working for Akums Drugs
Profit After Tax (PAT) - Latest six months
At Rs 124.22 cr has Grown at -47.11%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Non Operating Income - Quarterly
Highest at Rs 14.56 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income